PATENT CLAIM ANALYSIS

Application Number: 16254017
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "001810"]

Abstract:
Disclosed herein are  18 F-labeled compounds and compositions thereof. Also disclosed are methods of imaging estrogen receptor expressing tissues, or methods of identifying cancer lesions using these compounds.

Claim (Index 21):
The method of  claim 18 , wherein the cancer is breast cancer.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 99.0
- Lexical Diversity: 1.19231
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16169812', '16221201', '14649702', '15764988', '15531245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449428686990417
- 35 USC 102 Novelty (BERT): 0.4975836134952878
- Combined Prediction Score: 0.7202069431786664
- Mean Citation Score: 244.466104
- Max Citation Score: 257.54813
- Similarity Product: 203.1727395909924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test